January 2008
BioWorld Today;1/7/2008, Vol. 19 Issue 4, p7
This section offers business finance-related news briefs. Follica Inc. has raised $5.5 million in a Series A round led by Interwest Partners. Helicos BioSciences Corp. closed a senior secured credit facility with GE Healthcare Financial Services. Meanwhile, OSI Pharmaceuticals Inc. priced a private placement of $175 million aggregate principal amount of 3 percent convertible senior subordinated notes.


Related Articles

  • SEC Roundup.  // Private Placement Letter;11/29/99, Vol. 17 Issue 47, p4 

    Lists some of the companies offering convertible promisory notes through private placement in the United States. Clear Holdings Inc.; Earthcare Co.; Ugly Duckling Corp.; Earthcare Co.; Morris Mundy Inc.; Mylackey.com Inc.; Ugly Duckling Corp.; Walking Co.

  • Financings Roundup.  // BioWorld Today;12/22/2008, Vol. 19 Issue 247, p6 

    This article reports on the goal of Helicos BioSciences Corp. of Cambridge, Massachusetts, to raise about $18.6 million in gross proceeds. Helicos aims to get the funds through a private placement of shares of common stock and warrants. The company will use the proceeds for working capital and...

  • FINANCINGS ROUNDUP.  // BioWorld Today;4/5/2010, Vol. 21 Issue 64, p5 

    The article reports on the convertibility of the 2% convertible senior notes of OSI Pharmaceuticals Inc. at the discretion of the holders.

  • Financings Roundup.  // BioWorld Today;9/17/2009, Vol. 20 Issue 179, p6 

    The article reports on the move of Cambridge, Massachusetts-based Helicos BioSciences Corp. to enter a definitive agreements with new and existing investors in a bid to raise about 10 million dollars by private placement. The company is planning to sell about 1.03 million shares for 3.57 dollars...

  • Private Deal Flow Warms Up Slowly, New Year Pipeline Empty. Colomer, Nora // Private Placement Letter;01/08/2001, Vol. 19 Issue 1, p1 

    Focuses on the status of the private placement market in the United States as of January 8, 2001. Impact of the Federal Reserve Board's interest rate cut; Expectation for the private and public markets.

  • Financings Roundup.  // BioWorld Today;3/23/2010, Vol. 21 Issue 55, p3 

    The article reports on the statement of OSI Pharmaceuticals Inc. that it will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% convertible senior subordinated notes due 2023 under the terms of the indenture under which the notes were issued in September 2003.

  • FINANCINGS ROUNDUP.  // BioWorld Today;12/17/2009, Vol. 20 Issue 242, p8 

    This section offers news briefs on financing deals in the biotechnology industry. Amsterdam Molecular Therapeutics BV was able to raise five million euros through a private placement of convertible bonds. A bridge loan financing with Firebird Global Master Fund Ltd. was closed by AVAX...

  • Helicos again lowers IPO price; AtriCure in private $16.5M offer.  // Medical Device Daily;5/25/2007, Vol. 11 Issue 101, p2 

    The article offers news about financing deals. According to a filing with the Securities and Exchange Commission, Helicos BioSciences has lowered the expected price of its initial public offering for a second time. AtriCure has entered into definitive agreements with certain institutional...

  • Financings Roundup.  // BioWorld Today;9/7/2011, Vol. 22 Issue 173, p5 

    The article reports that Genta Inc. raised 4.2 million U.S. dollars in the initial tranche of a private placement of senior secured convertible notes.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics